Clinical trial
A Group Wide Biology and Banking Study for Phase II Study of R1507
NCT00923325 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Group Wide Biology and Banking Study for Phase II Study of R1507
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 9, 2008
- Completion date
- May 18, 2017
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sarcomas